"Designing Growth Strategies is in our DNA"
The U.S. hemodialysis equipment market size was worth USD 4.98 billion in 2022 and is projected to grow at a CAGR of 6.5% during the forecast period.
Hemodialysis equipment is used to filter patient’s blood suffering from kidney failure. The equipment includes dialysis pumping machines, dialyzers, and other access products, including catheters, blood pumps, and tubing kits. The growth in the U.S. hemodialysis equipment market is mainly driven by factors such as the increasing number of chronic kidney diseases, technological advancements, and initiatives undertaken by major market players to introduce advanced products in the market.
The rising prevalence of risk factors such as obesity, diabetes, hypertension, and the aging population has contributed to the growing incidence of chronic kidney diseases. To meet the increasing needs of renal replacement therapy patients, the demand for hemodialysis equipment is projected to increase in the near future.
However, in 2020, the outbreak of the COVID-19 pandemic caused a restricted market growth due to the lockdown restrictions and disruptions in supply chains. The reduced number of dialysis patients due to increased mortality due to COVID-19 has resulted in slower market growth. Several market players offering hemodialysis products witnessed a decline in their revenues as a result of decreased patient pool during the pandemic.
Shift Toward Home-Based Hemodialysis is a Significant Market Trend
The demand for home-based hemodialysis equipment is increasing due to its beneficial factors, such as convenience, flexibility, infection control, and cost-effectiveness. Additionally, the growing awareness regarding the benefits of home-based hemodialysis stimulates several manufacturers to increase their clinical research activities for introducing home-based hemodialysis machines. Further, manufacturers are undertaking various initiatives, such as partnerships and collaborations, to launch new products that can empower patients to choose home dialysis.
Growing Prevalence of Chronic Kidney Disease to Drive Market Growth
Chronic kidney disease incidence has increased in the U.S. due to factors such as diabetes, the aging population, obesity, and hypertension. According to data published by National Kidney Foundation Inc., around 37 million people in the U.S. are affected by kidney diseases. The progression of kidney disease is projected to influence the demand for dialysis to maintain proper kidney functioning.
Dialysis is a lifesaving treatment which helps to destroy waste products and excess fluid in the blood if kidney is not able to function properly. The demand for dialysis equipment such as dialyzers, hemodialysis machines, and dialysis concentrate is anticipated to increase owing to the growing number of dialysis patients. Thus, the influence of above-mentioned factors is anticipated to propel the U.S. hemodialysis equipment market growth.
Download Free sample to learn more about this report.
According to data published by the Centers for Disease Control and Prevention in 2023, the women demographic is more prone to chronic kidney disease, with an estimated prevalence of 14.4% in 2023.
Adverse Effects of the Equipment May Hamper the Market Growth
According to a recent study, hemodialysis machines expose patients to certain toxic compounds. The silicone tubing used in the machine as a part of the hydraulics and the dialysate lines contains some form of chemicals. As per the data published by the FDA (Food and Drug Administration) in May 2022, they are assessing certain Fresenius Medical Care hemodialysis machines: the 2008T, 2008 K2, and 2008K models. Furthermore, the FDA is working with the manufacturers to develop strategies to regulate the risk of exposure to non-dioxin-like (NDL) polychlorinated biphenyls (PCBs) and NDL polychlorinated biphenyl acids (PCBAs) in patients. Furthermore, the availability of alternative treatment options such as kidney transplants is expected to hinder growth prospects.
Hence, these adverse effects and high costs associated with hemodialysis equipment limit the growth of the market to a certain extent.
Based on product, the U.S. hemodialysis equipment market is segmented into hemodialysis machines and hemodialysis consumables.
In 2022, the hemodialysis consumables segment held a dominating U.S. hemodialysis equipment market share. This can be attributed to the growing adoption of treatment options associated with kidney failure. Furthermore, an increasing number of product approvals from regulatory bodies and technological advancements are projected to drive the growth of this segment over the forecast period.
On the other hand, the hemodialysis machines segment is expected to grow at a significant CAGR over the forecast period. This is due to the growing prevalence of kidney diseases, rising awareness about treatment options, and the introduction of new products.
Based on end-user, the U.S. hemodialysis equipment market is divided into dialysis centers & hospitals and home healthcare.
In 2022, the dialysis centers & hospitals segment accounted for the highest market share owing to high patient volume compared to home healthcare. Hospitals are equipped with cutting-edge infrastructure, strong support services, and specialized staff to provide excellent dialysis therapy.
Besides, the home healthcare segment is projected to expand at the highest CAGR over the study period. Increasing reimbursement policies by the government to support innovations and new products launched for homecare settings is projected to boost the segmental growth in the near future.
The U.S. hemodialysis equipment market involves several established and emerging players. Fresenius Medical Care AG & Co. KGaA and Baxter are the prominent players in the market due to their strong dialysis product portfolio, such as dialysis machines or dialyzers. In addition, these manufacturers are focusing on expansion in the field of critical care and complementary areas. For instance, in August 2022, Fresenius Medical Care closed a three-way merger and created a premier value-based kidney care provider in the U.S. The new company aims to provide proper care for more than 270,000 Americans living with kidney disease.
Some other players, such as B. Braun SE, NIPRO CORPORATION, Asahi Kasei Corporation, Nikkiso Co., Ltd., and others, are striving to gain a higher market share. These companies are focusing on strengthening their market position by undertaking various strategic initiatives such as new product launches, collaboration & partnerships, and others.
An Infographic Representation of U.S. Hemodialysis Equipment Market
To get information on various segments, share your queries with us
The U.S. hemodialysis equipment market report provides a detailed analysis of the industry. It focuses on key aspects such as an overview of technological advancements, the prevalence of kidney disorders in the U.S. and key industry developments such as mergers, partnerships, and acquisitions. In addition, it includes new product launches and the impact of COVID-19 on the market. Besides this, the report offers insights into the market trends, competitive landscape, and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market over recent years.
To gain extensive insights into the market, Download for Customization
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2019-2030 |
|
Base Year |
2022 |
|
Estimated Year |
2023 |
|
Forecast Period |
2023-2030 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 6.5% from 2023 to 2030 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
By Product
|
|
By End-user
|
Fortune Business Insights says that the U.S. market was worth USD 4.98 billion in 2022.
The market is expected to exhibit a CAGR of 6.5% during the forecast period (2023-2030).
By product, the hemodialysis consumables segment accounted for a key share in the market.
Fresenius Medical Care AG & Co. KGaA and Baxter are the top players in the market.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )